- Home
- NKSH vs RPID Comparison
NKSH vs RPID Comparison
Compare NKSH & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NKSH | RPID |
|---|---|---|
| Founded | 1891 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.3M | 204.3M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NKSH | RPID |
|---|---|---|
| Price | $36.39 | $2.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 26.2K | ★ 263.3K |
| Earning Date | 04-23-2026 | 05-08-2026 |
| Dividend Yield | ★ 4.15% | N/A |
| EPS Growth | ★ 100.81 | 2.78 |
| EPS | ★ 2.49 | N/A |
| Revenue | $8,176,000.00 | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | N/A | $18.42 |
| P/E Ratio | $14.61 | ★ N/A |
| Revenue Growth | 9.39 | ★ 19.74 |
| 52 Week Low | $23.75 | $1.86 |
| 52 Week High | $40.00 | $4.94 |
Technical Indicators
Market Signals| Indicator | NKSH | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 32.95 |
| Support Level | $35.42 | N/A |
| Resistance Level | $38.39 | $4.48 |
| Average True Range (ATR) | 0.89 | 0.20 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 31.51 | 26.00 |
Price Performance
Historical ComparisonAbout NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.